A Randomized Clinical Trial of Energy Conservation for Patients with Cancer-Related Fatigue

Cancer

Volumn 100, Issue 6, 2004, Pages 1302-1310

  Barsevick, Andrea M ^a   Dudley, William ^b   Beck, Susan ^b   Sweeney, Carole ^a   Whitmer, Kyra ^c   Nail, Lillian ^d  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Fatigue; Quality of life; Symptom clusters; Symptom management

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY CONSERVATION; FATIGUE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NURSE; NURSING; NUTRITION; ONCOLOGY; OUTCOMES RESEARCH; PATIENT CARE; PERFORMANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TELEPHONE; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ENERGY METABOLISM; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; NUTRITION PHYSIOLOGY; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 1542374047     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20111     Document Type: Article

References (58)

1. Portenoy RK, Miaskowski C. Assessment and management of cancer-related fatigue. In: Berger A, Portenoy RK, Weissman D, editors. Principles and practice of supportive care. Philadelphia: Lippincott-Raven, 1998:109-118.
2. Irvine DM, Vincent L, Graydon JE, Bubela N. Fatigue in women with breast cancer receiving radiation therapy. Cancer Nurs. 1998;21:127-135.
3. McDaniel RW, Rhodes VA. Fatigue. In: Yarbro CH, Frogge MH, Goodman M, Groenwald M, editors. Cancer nursing (5th edition). Boston: Jones & Bartlett, 2000:737-753.
4. Hann DM, Garovoy N, Finkelstein B, Jacobsen PB, Azzarello LM, Fields KK. Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: a longitudinal comparative study. J Pain Symptom Manage. 1999;17:311-319.
5. Winningham ML. Fatigue. In: Yarbro CH, Frogge MH, Goodman M, editors. Cancer symptom management, 2nd edition. Boston: Jones & Bartlett, 1999:58-76.
6. Winningham ML, Nail LM, Burke MB, et al. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum. 1994;21:23-36.
7. Stone P, Richards M, A'Hern R, Hardy J. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage. 2001;22:1007-1015.
8. Longman AJ, Braden CJ, Mishel MH. Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time. Oncol Nurs Forum. 1999;26:909-915.
9. Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Fatigue and psychiatric morbidity among Hodgkin's disease survivors. J Pain Symptom Manage. 2000;19:91-99.
10. Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist. 2000;5:353-360.
11. Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage. 1999;18:233-242.
12. Akechi T, Kugaya A, Okamura H, Yamawaki S, Uchitomi Y. Fatigue and its associated factors in ambulatory cancer patients: a preliminary study. J Pain Symptom Manage. 1999;17:42-48.
13. Rosenthal MA, Oratz R. Phase II clinical trial of recombinant alpha 2b interferon and 13 cis retinoic acid in patients with metastatic melanoma. Am J Clin Oncol. 1998;21:352-354.
14. Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of Cancer survivors. J Clin Oncol. 2001;19:3385-3391.
15. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16:1689-1696.
16. Dancey J, Zee B, Osoba D, et al. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res. 1997;6:151-158.
17. Cella D, Fairclough DL, Bonomi PB, Kim K, Johnson DH. Quality of life (QOL) in advanced non-small cell lung cancer (NSCLC): results from Eastern Cooperative Oncology Group (ECOG) study E5592 [abstract]. Proc Am Soc Clin Oncol. 1997;16:2a.
18. Herndon JE II, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer. 1999;85:333-340.
19. Porock D, Kristjanson LJ, Tinnelly K, Duke T, Blight J. An exercise intervention for advanced cancer patients experiencing fatigue: a pilot study. J Palliat Care. 2000;16:30-36.
20. Segal R, Evans W, Johnson D, et al. Structured exercise improves physical functioning in women with Stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol. 2001;19:657-665.
21. Dimeo F, Stieglitz RD, Novelli-Fischer U, Fetscher S, Mertelsmann R, Keul J. Correlation between physical performance and fatigue in cancer patients. Ann Oncol. 1997;8:1251-1255.
22. Dimeo F, Fetscher S, Lange W, Mertelsmann R, Keul J. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood. 1997;90:3390-3394.
23. Dimeo FC, Tilmann MH, Bertz H, Kanz L, Mertelsmann R, Keul J. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer. 1997;79:1717-1722.
24. Ream E, Richardson A. From theory to practice: designing interventions to reduce fatigue in patients with cancer. Oncol Nurs Forum. 1999;26:1295-1303; quiz, 1304-1305.
25. Mock V, Pickett M, Ropka ME, et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract. 2001;9:119-127.
26. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol. 1997;15:1218-1234.
27. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol. 1998;16:3412-3425.
28. Nail LM. Fatigue in patients with cancer. Oncol Nurs Forum. 2002;29:537.
29. Richardson A, Ream E. Self-care behaviours initiated by chemotherapy patients in response to fatigue. Int J Nurs Stud. 1997;34:35-43.
30. Mock V. Fatigue management: evidence and guidelines for practice. Cancer. 2001;92(6 Suppl):1699-1707.
31. Ream E, Richardson A. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud. 1997;34:44-53.
32. Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology (Huntingt). 2000;14:151-161.
33. Donovan HS, Ward S. A representational approach to patient education. J Nurs Scholarsh. 2001;33:211-216.
34. Brownlee S, Leventhal H, Leventhal EA. Regulation, self-regulation, and construction of the self in the maintenance of physical health. In: Boekaerts M, Pintrich PR, editors. Handbook of self-regulation. San Diego: Academic Press, 2000:369-416.
35. Diefenbach MA, Leventhal H. The common-sense model of illness representation: theoretical and practical considerations. J Soc Distress Homeless. 1996;5:11-38.
36. Barsevick AM, Whitmer K, Walker L. In their own words: using the common sense model to analyze patient descriptions of cancer-related fatigue. Oncol Nurs Forum. 2001;28:1363-1369.
37. Ward SE. The common sense model: an organizing framework for knowledge development in nursing. Sch Inq Nurs Pract. 1993;7:79-90; discussion, 91-94.
38. Keller ML, Ward S, Baumann LJ. Processes of self-care: monitoring sensations and symptoms. ANS Adv Nurs Sci. 1989;12:54-66.
39. Stuifbergen AK, Rogers S. The experience of fatigue and strategies of self-care among persons with multiple sclerosis. Appl Nurs Res. 1997;10:2-10.
40. Small S, Lamb M. Fatigue in chronic illness: the experience of individuals with chronic obstructive pulmonary disease and with asthma. J Adv Nurs. 1999;30:469-478.
41. Mathiowetz V, Matuska KM, Murphy ME. Efficacy of an energy conservation course for persons with multiple sclerosis. Arch Phys Med Rehabil. 2001;82:449-456.
42. Halbritter T. Management of a patient with post-polio syndrome. J Am Acad Nurse Pract. 2001;13:555-559.
43. Furst GP, Gerber LH, Smith CC, Fisher S, Shulman B. A program for improving energy conservation behaviors in adults with rheumatoid arthritis. Am J Occup Ther. 1987;41:102-111.
44. Barsevick AM, Whitmer K, Sweeney C, Nail LM. A pilot study examining energy conservation for cancer treatment-related fatigue. Cancer Nurs. 2002;25:333-341.
45. Meek PM, Nail LM, Barsevick A, et al. Psychometric testing of fatigue instruments for use with cancer patients. Nurs Res. 2000;49:181-190.
46. Brown J, Byers T, Thompson K, Eldridge B, Doyle C, Williams AM. Nutrition during and after cancer treatment: a guide for informed choices by cancer survivors. CA Cancer J Clin. 2001;51:153-187; quiz, 189-192.
47. McNair DM, Lorr M, Droppleman LF. Profile of mood states manual (2nd edition). San Diego: Educational and Industrial Testing Service, 1992.
48. Schwartz AL. The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum. 1998;25:711-717.
49. Meek P, Nail LM, Jones LS. Internal consistency reliability and construct validity of a new measure of cancer treatment related fatigue: the General Fatigue Scale (GFS). Oncol Nurs Forum. 1997;24:334.
50. Leidy NK. Functional status and the forward progress of merry-go-rounds: toward a coherent analytical framework. Nurs Res. 1994;43:196-202.
51. Larson JL, Kapella MC, Wirtz S, Covey MK, Berry J. Reliability and validity of the functional performance inventory in patients with moderate to severe chronic obstructive pulmonary disease. J Nurs Meas. 1998;6:55-73.
52. Leidy NK. Psychometric properties of the Functional Performance Inventory in patients with chronic obstructive pulmonary disease. Nurs Res. 1999;48:20-28.
53. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed models. Cary, NC: SAS Institute, 1996.
54. Schwartz AL, Meek PM, Nail LM, et al. Measurement of fatigue. Determining minimally important clinical differences. J Clin Epidemiol. 2002;55:239-244.
55. Dineen K, Hahn EA, Cashy J, Cella D. Does the direction of change (better or worse) matter? A reanalysis of evidence. Clin Ther. 2003;25(Suppl D):D31-D32.
56. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001;28:465-470.
57. Dodd M, Janson S, Facione N, et al. Advancing the science of symptom management. J Adv Nurs. 2001;33:668-676.
58. Given CW, Given B, Azzouz F, Kozachik S, Stommel M. Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage. 2001;21:456-466.